RMD – ResMed Inc.
RMD — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
8.18
Margin Of Safety %
26
Put/Call OI Ratio
2.83
EPS Next Q Diff
0.08
EPS Last/This Y
1.47
EPS This/Next Y
1.15
Price
220.48
Target Price
307.95
Analyst Recom
1.9
Performance Q
-9.81
Upside
1.0%
Beta
0.93
Ticker: RMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | RMD | 257.42 | 2.69 | 1.59 | 11991 |
| 2026-03-04 | RMD | 259.11 | 2.67 | 7.42 | 12020 |
| 2026-03-05 | RMD | 255.41 | 2.78 | 1.37 | 12374 |
| 2026-03-09 | RMD | 252.85 | 2.77 | 4.10 | 12426 |
| 2026-03-10 | RMD | 247.12 | 2.77 | 1.32 | 12426 |
| 2026-03-11 | RMD | 240.18 | 2.76 | 1.26 | 12448 |
| 2026-03-12 | RMD | 232.43 | 2.67 | 2.13 | 12752 |
| 2026-03-17 | RMD | 233.55 | 2.69 | 1.50 | 12773 |
| 2026-03-18 | RMD | 227.9 | 2.69 | 0.77 | 12817 |
| 2026-03-19 | RMD | 227.36 | 2.69 | 1.02 | 12833 |
| 2026-03-20 | RMD | 225.94 | 2.69 | 1.65 | 12803 |
| 2026-03-23 | RMD | 227.94 | 2.91 | 0.70 | 13119 |
| 2026-03-24 | RMD | 228.26 | 2.88 | 1.19 | 13134 |
| 2026-03-25 | RMD | 226.32 | 2.87 | 0.74 | 13152 |
| 2026-03-26 | RMD | 222.52 | 2.86 | 0.93 | 13225 |
| 2026-03-27 | RMD | 220.53 | 2.83 | 5.08 | 13168 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | RMD | 256.26 | 18.5 | 193.8 | 11.03 |
| 2026-03-02 | RMD | 257.29 | 18.5 | 68.0 | 11.03 |
| 2026-03-03 | RMD | 258.32 | 18.5 | 243.9 | 11.03 |
| 2026-03-04 | RMD | 259.09 | 18.5 | 242.8 | 11.03 |
| 2026-03-05 | RMD | 255.35 | 18.5 | 206.0 | 11.03 |
| 2026-03-06 | RMD | 252.81 | 18.5 | 215.2 | 11.03 |
| 2026-03-09 | RMD | 252.91 | 18.5 | 236.5 | 11.03 |
| 2026-03-10 | RMD | 247.12 | 18.5 | 187.8 | 11.03 |
| 2026-03-11 | RMD | 240.21 | 18.5 | 177.2 | 11.03 |
| 2026-03-12 | RMD | 232.50 | 18.5 | 168.9 | 11.03 |
| 2026-03-13 | RMD | 230.82 | 18.5 | 221.8 | 11.03 |
| 2026-03-17 | RMD | 233.44 | 18.4 | 262.1 | 11.03 |
| 2026-03-18 | RMD | 228.06 | 18.4 | 186.9 | 11.02 |
| 2026-03-19 | RMD | 227.46 | 18.4 | 232.3 | 11.02 |
| 2026-03-20 | RMD | 226.05 | 18.4 | 223.5 | 11.02 |
| 2026-03-23 | RMD | 228.01 | 18.4 | 255.1 | 11.02 |
| 2026-03-24 | RMD | 228.19 | 18.4 | 238.3 | 11.02 |
| 2026-03-25 | RMD | 226.31 | 18.4 | 218.8 | 11.02 |
| 2026-03-26 | RMD | 222.49 | 18.4 | 200.5 | 11.02 |
| 2026-03-27 | RMD | 220.48 | 18.4 | 217.0 | 11.02 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | RMD | -6.13 | 1.55 | 6.98 |
| 2026-03-02 | RMD | -6.12 | 2.36 | 6.98 |
| 2026-03-03 | RMD | -6.12 | 2.36 | 6.98 |
| 2026-03-04 | RMD | -5.94 | 2.36 | 6.98 |
| 2026-03-05 | RMD | -6.13 | 2.36 | 6.98 |
| 2026-03-06 | RMD | -6.13 | 2.36 | 6.98 |
| 2026-03-09 | RMD | -6.13 | 2.34 | 6.98 |
| 2026-03-10 | RMD | -5.37 | 2.34 | 6.98 |
| 2026-03-11 | RMD | -5.84 | 2.34 | 8.18 |
| 2026-03-12 | RMD | -5.84 | 2.34 | 8.18 |
| 2026-03-13 | RMD | -5.84 | 2.34 | 8.18 |
| 2026-03-17 | RMD | -5.84 | 2.55 | 8.18 |
| 2026-03-18 | RMD | -5.84 | 2.55 | 8.18 |
| 2026-03-19 | RMD | -5.84 | 2.55 | 8.18 |
| 2026-03-20 | RMD | -5.85 | 2.55 | 8.18 |
| 2026-03-23 | RMD | -5.84 | 2.33 | 8.18 |
| 2026-03-24 | RMD | -5.84 | 2.33 | 8.18 |
| 2026-03-25 | RMD | -5.84 | 2.33 | 8.18 |
| 2026-03-26 | RMD | -5.84 | 2.33 | 8.18 |
| 2026-03-27 | RMD | -5.84 | 2.33 | 8.18 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.81
Avg. EPS Est. Current Quarter
2.81
Avg. EPS Est. Next Quarter
2.89
Insider Transactions
-5.84
Institutional Transactions
2.33
Beta
0.93
Average Sales Estimate Current Quarter
1425
Average Sales Estimate Next Quarter
1463
Fair Value
277.44
Quality Score
84
Growth Score
97
Sentiment Score
33
Actual DrawDown %
26.8
Max Drawdown 5-Year %
-54
Target Price
307.95
P/E
21.79
Forward P/E
17.96
PEG
1.49
P/S
5.95
P/B
5.08
P/Free Cash Flow
17.93
EPS
10.12
Average EPS Est. Cur. Y
11.02
EPS Next Y. (Est.)
12.18
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
27.53
Relative Volume
0.91
Return on Equity vs Sector %
-3.8
Return on Equity vs Industry %
13.9
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
217
◆
RMD
Healthcare
$220.47
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
26
Range 1M
2.2%
Sup Dist
0.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
15.8%
EPS NY
11%
52W%
21.7%
Long-Term Value
Quality companies, undervalued
WATCH
🟡 HOLD
+26.4% upside
Upside
+26.4%
Quality
84
MoS
26%
ResMed Inc.Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees:
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
RMD
Latest News
—
Caricamento notizie per RMD…
stock quote shares RMD – ResMed Inc. Stock Price stock today
news today RMD – ResMed Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RMD – ResMed Inc. yahoo finance google finance
stock history RMD – ResMed Inc. invest stock market
stock prices RMD premarket after hours
ticker RMD fair value insiders trading